# Dongwha Pharm

> Dongwha Pharm is a VC fund backing Biotechnology, Pet and Mobile. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Nov 2023
- Lead investor: 20%
- Last updated: Aug 2026
- Website: http://www.dong-wha.co.kr

Dongwha Pharm is a VC fund focused on Biotechnology and Pet. Dongwha Pharm offers drugs such as antipyretics, analgesics, and antibiotics for cardiovascular, and alimentary ailments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Pet | 1 | 20% |
| Mobile | 1 | 20% |
| Android | 1 | 20% |
| Medical | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 60% |
| Corporate Round | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 4 | 80% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oncocross | Oncocross is a Biopharmaceutical Company. | $11M | Venture - Series Unknown | Nov 13, 2023 |  |
| Fitpet | Fitpet's mission to create sustainable and wholesome pet-friendly society with IT over the world. | $3.8M | Corporate Round | Mar 21, 2023 |  |
| HAII | HAII is a theranostics companion platform that offers treatments developed by AI data analytics. | $5.6M | Series B | Nov 23, 2022 |  |
| Organoid Sciences | Organoid Sciences is an organoid-based treatment drug development company that offers drug screening and regenerative medicines. | $15.1M | Series B | Nov 22, 2021 |  |
| BBB | “Everyone has the equal right of receiving medical services and treatments”BBB Tech headquartered in Silicon Valley is a mobile healthcare tech startup. It manufactured Android-powered real-time mobile blood diagnostic device “Elemark” testing + 50 diagnostic conditions in 2-60 seconds with one drop of blood and an integrated service platform toprovide actionable insights.- Established Date : October 20th, 2014- Performance & Awards▶1st Winner of 2015 TechCrunch Seoul▶2015 TechCrunch New York Disrupt Startup Alley▶2015 Winner of TechinAsia @beGlobal Seoul▶HAX batch 6, Global Hardware Accelerator Program | $12.3M | Series B | Oct 31, 2018 |  |

5 of 5 investments shown.

## Co-investors
- [Asan Foundation](https://shizune.co/investors/profile/asan-foundation) — VC Fund, 1 deal together
- [Bokwang Investment](https://shizune.co/investors/profile/bokwang-investment) — VC Fund, 1 deal together
- [Capstone Partners](https://shizune.co/investors/profile/capstone-partners-korea) — VC Fund, 1 deal together
- [CJ Investment](https://shizune.co/investors/profile/cj-investment) — VC Fund, 1 deal together
- [HB Investment](https://shizune.co/investors/profile/hb-investment) — VC Fund, 1 deal together
- Intervest — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Dongwha Pharm invest in?

Dongwha Pharm invests primarily in Biotechnology, Pet and Mobile startups, most often at Series B and Corporate Round stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dongwha Pharm last invest?

The most recent investment recorded for Dongwha Pharm closed in Nov 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co